StockMarketWire.com - Diurnal Group (DNL) is a specialty pharmaceutical company developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia, Adrenal Insufficiency, Hypogonadism and Hypothyroidism.
The Shares and AJ Bell Media evening event webinar is an opportunity for senior board directors from listed PLCs to make a presentation about their company and update existing & potential investors on their business plans for 2020 Investors will have the chance to discover investment opportunities and get to know the companies better by asking questions online after the presentations
Other companies presenting via the webinar include: ReNeuron Group - Frenkel Topping
Sponsored by: AJ Bell Youinvest
Shareholders and potential investors can register to join the webinar for free at:
https://www.sharesmagazine.co.uk/events/event/shares-investor-evening--webinar-020321
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.